<MedlineCitation Status="Completed">
<MedlineID>10011446</MedlineID>
<PMID>105760</PMID>
<DateCreated>
<Year>1979</Year>
<Month>05</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>05</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0006-3002</ISSN>
<JournalIssue>
<Volume>566</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1979</Year>
<Month>Feb</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Thyroid purine nucleoside phosphorylase. II. Kinetic model by alternate substrate and inhibition studies.</ArticleTitle>
<Pagination>
<MedlinePgn>259-65</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Nucleoside analog inhibition studies have been conducted on thyroidal purine nucleoside phosphorylase (purine-nucleoside:orthophosphate ribosyltransferase, EC 2.4.2.1) which catalyzed an ordered bi-bi type mechanism where the first substrate is inorganic phosphate and the last product is ribose 1-phosphate. Heterocyclic- and carbohydrate-modified nucleoside inhibitors demonstrate mixed type inhibition suggesting such analogs show an affinity (Ki) for the free enzyme. A kinetic model is proposed which supports the observed inhibition patterns. These studies together with alternate substrate studies indicate that nucleoside binding requires a functional group capable of hydrogen bonding at the 6-position of the purine ring and that the orientation of the bound substrate may be syn. Proper geometry of the phosphate is dependent upon the 3'-substituent to the orientated below the furanose ring. The 5'-hydroxyl group is required for substrate activity. The proposed rate limiting step of the phosphorylase mechanism is the enzymatic protonation of the 7-N position of the nucleoside.</AbstractText>
</Abstract>
<AuthorList>
<Author>
<LastName>Carlson</LastName>
<ForeName>J D</ForeName>
<Initials>JD</Initials>
</Author>
<Author>
<LastName>Fischer</LastName>
<ForeName>A G</ForeName>
<Initials>AG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Biochim Biophys Acta</MedlineTA>
<NlmUniqueID>0217513</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Phosphates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>58-63-9</RegistryNumber>
<NameOfSubstance>Inosine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.4.2.</RegistryNumber>
<NameOfSubstance>Pentosyltransferases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.4.2.1</RegistryNumber>
<NameOfSubstance>Purine-Nucleoside Phosphorylase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Cattle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Inosine</DescriptorName>
<QualifierName>analogs &#38; derivatives</QualifierName>
<QualifierName>metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Mathematics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Pentosyltransferases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Phosphates</DescriptorName>
<QualifierName>metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Purine-Nucleoside Phosphorylase</DescriptorName>
<QualifierName>antagonists &#38; inhibitors</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Substrate Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Thyroid Gland</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
